Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
Home About Us How To Help Contact Us Search

What Is Proton Therapy?

Principles of Proton Therapy

The Treatment Team

Treatment Options

Frequently Asked Questions (FAQ's)

What To Expect:
Appointments

Videos

Proton Therapy - In the News

 

< Radiation Oncology

< About Us

Medulloblastoma
Medulloblastoma is the most common malignant pediatric brain tumor. It develops in the part of the brain that controls balance and coordination. It is also a fast-growing cancer that often spreads to the central nervous system. By using Proton Beam radiation in these cases allows the special radiation to be targeted to the tumor while minimizes radiation to healthy tissue and other critical structures in the brain and spine. As with all other proton therapy treatments the goal is to minimize the dose to adjacent normal structures minimizing treatment related complications. Pediatric patients may benefit the most from such treatments because of the potential harm to growing organs and bones from receiving conventional radiation therapy alone.

See Enlarged Image

Proton radiation ensures that no dose reaches the anterior pelvic and thoracic structures when treating the entire spinal column. The dose to the whole brain and spinal column is very uniform preventing regions of unwanted high doses. The base of skull is irradiated to a higher dose while avoiding the cochlea (blue outline) as much as possible.

Radiation Therapy with Standard X-Rays and Protons for Medulloblastoma
For certain tumors of the brain, radiation is given to the back of the brain (posterior fossa). With standard radiation there is incidental dose given to healthy brain tissue surrounding the tumor. An example of this is the cochlea, the organ in the middle ear that is responsible for bringing sound into the ear through the nerves. Injury to the cochlea can have the potential long-term effect of hearing loss. One benefit of proton therapy is the ability to shape the radiation so that less dose is delivered to the cochlea. Clinical studies are under way to determine the long term affects in children.

See Enlarged Image

See Enlarged Image

 

Harvard Medical School - Teaching Affiliate  
Previous Page | To Top